Aytu BioScience Stock Price - AYTU

-0.16 (-9.52%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aytu BioScience Inc AYTU NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.16 -9.52% 1.52 1.42 1.59 1.55 1.68 15:35:32
Bid Price Ask Price Spread Spread % News
1.51 1.52 0.01 0.66% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
28,235 14,345,441 $ 1.52 $ 21,828,937 31,734,700 0.3352 - 2.99
Last Trade Time Type Quantity Stock Price Currency
15:35:48 8 $ 1.52 USD

Aytu BioScience Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 117.62M 78.41M $ -10.19M -4.48 - 76.52M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Aytu BioScience News

Loading Messages....

Latest AYTU Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AYTU Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.102.241.421.8231,778,762-0.58-27.62%
1 Month0.562.990.33521.6945,020,4600.96171.43%
3 Months0.962.990.33521.6815,950,7850.5658.33%
6 Months1.272.990.33521.677,373,2560.2519.69%
1 Year1.702.990.33521.683,917,391-0.18-10.59%
3 Years6.356.960.2329631.422,287,599-4.83-76.06%
5 Years6.356.960.2329631.422,287,599-4.83-76.06%

Aytu BioScience Description

Aytu BioScience Inc is a specialty pharmaceutical company commercializing novel products addressing patient needs. The company markets a portfolio of prescription products addressing large therapeutic markets. The primary care portfolio includes Natesto, the only FDA-approved nasal formulation of testosterone, ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes AcipHex Sprinkle, Cefaclor, Karbinal ER, and Poly-Vi-Flor and Tri-Vi-Flor.

Your Recent History
Aytu BioSc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.